Connect with us

News

SUCCESS: Congress Grants Charlie Gard U.S. Citizenship

There was plenty of fear-mongering over “death panels” under Obamacare – but even Obamacare isn’t “socialized medicine.” For those living under socialized medicine, rationing of care is commonplace – and it’s ultimately the government that determines your fate if you’re unfortunate enough to need a particularly expensive treatment.

It’s a tradeoff that’s impossible to not make when operating under a public healthcare system with limited resources – but the case of Charlie Gard was different. The ten-month-old who suffers a rare mitochondrial disease was effectively sentenced to death by the U.K.’s High Court – despite the fact that Charlie’s parents had privately raised enough money to bring him to the U.S. for experimental treatment. There would be no burden on the U.K.’s National Health Service – and yet he was still sentenced to die. To make matters worse, Charlie’s parents weren’t even allowed to bring him home.

That’s how much power the state influenced over a life – and for seemingly no purpose. Luckily public outrage was enough to influence the case, with even President Donald Trump and Pope Francis offering aid.

https://twitter.com/realDonaldTrump/status/881875263700783104

Now finally, after months of going through an emotionally grueling process, Charlie’s parents are finally being given the opportunity to bring their child to the U.S.

According the Independent, Charlie Gard has reportedly been granted U.S. citizenship so he can travel to America to receive experimental treatment.
The decision by the U.S. Congress to give the 11-month-old citizenship may oblige Great Ormond Street Hospital to release the sick baby so he can receive nucleoside therapy.

Nebraska representative Jeff Fortenberry said an amendment has been passed “that grants permanent resident status to Charlie Gard and family so Charlie can get the medical treatment he needs”. An American doctor flew to London this week to examine the critically ill baby as part of a last-ditch attempt to persuade a High Court judge the treatment stands a chance of working.Charlie, who was born on 4 August 2016, has a faulty RRM2B gene, which affects the cells responsible for energy production and respiration, leaving him unable to move or breathe without a ventilator.

Dr Michio Hirano, a neuroscientist from Columbia University in New York, is said to have spent over five hours trying to convince doctors, along with an expert from a Vatican hospital in Rome.
The specialist told the High Court nucleoside therapy has a 10 per cent chance of improving Charlie’s condition, adding his research “clearly indicates” it reduces muscle weakness in patients with a similar genetic disorder.

How ironic that as Democrats fear-monger about Republicans “killing people” because of their attempts to repeal Obamacare, it’s a Republican Congress that possibly saved this child from the horrors of socialized medicine.

Continue Reading
Advertisement
2 Comments

2 Comments

  1. Sally Greenberg

    July 19, 2017 at 4:26 pm

    Yes, it IS ironic, especially in view, also, of what happened yesterday (Tues., July 18) with the new PROPOSED healthcare bill being dcrapped due to lack of support on both sides of yhe aisle!!! I’m happy for Chsrlie and his family, but frustrated and sad that politics got in the way of sn sttempt to fix the healthcare system in this country!!! We don’t need socialized medicine in this country, and this vhild’s case js a perfect example of wjy not!!! Praise God that our pkliticians saw fit to help thid child and hid [email protected]!

  2. Joan

    July 19, 2017 at 6:56 pm

    Good news that Angel Charlie and his parents, thanks to USA Republicans, can become citizens thus enabling Angel Charlie to get treatment BUT WHILE THIS IS ALL GOOD, TIME IS OF THE ESSENCE. GOSH AND COURTS ARE TAKING VALUABLE TIME AWAY FROM ANGEL CHARLIE’S TREATMENT BREATHE YOU FOOLS AND MAKE AN AFFIRMATIVE DECISION YESTERDAY NOT 7/25 THIS IS A HUMAN BEING
    GET WITH THE MO!!!!!

Leave a Reply

Your email address will not be published. Required fields are marked *

CF